ArticleFrontiers in oncology2022

Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge.

Matthew Scarlotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.